EN >
medmesafe
EN >
Services
EN >
You will receive an e-mail with instructions to reset your password
Newborn
Early detection of genetic diseases that appear in the early years of life.
Newborn
analysis provides information for preventive treatment, diet or early treatment of genetic diseases that appear during the early stages of life.
Knowing this information is key, as 65% of diseases are treatable by diet or by an early approach, before symptoms appear.
9,4%
Up to 9.4% of newborns
may have genetic variations related to childhood-onset diseases.(1)
100%
The test can be performed on any newborn
who has no symptoms of illness, as part of his or her medical care.
390
This analysis complements the biochemical heel prick test,
increasing the number of diseases detected to 390 and increasing clinical utility.
407
Analysis detects variants in 407 genes
related to metabolic and genetic diseases that appear in the first years of life.
Newborn
- Accurately detects more than 390 diseases that can affect the newborn early in life
- Identifies variants in 407 genes related to metabolic and genetic diseases that appear in the first years of life.
- You will receive a vídeo follow-up before and after the analysis by a genetic counsellor listed by medmesafe.
Download results report
4-6 weeks
Spain
Saliva
Whole Exome Secuencing
- Counting from the reception of the sample in the laboratory (Shipping costs included in Spain).
- Spain
- Collection of saliva.
- Whole exome sequencing (WES) with illumina platform (HiSeq X10, NovaSeq 6000).
- Average coverage 110x sequencing >97% at ≥20x achieving a 300x average coverage in the genes of the panel.
- CLIA-certifed laboratory (CLIA #22D2089381).
- CAP accreditation (College of American Pathologists).
- All the reports are reviewed by an expert medical team with more than 10 years of experience in Whole Genome and Exome sequencing, including members of the Personal Genome Project of Harvard Medical School.
- Possible Outcomes:
- Pathogenic variants and probably pathogenic variants are reported
- The only recessive conditions reported are those with impact on newborn health, the rest are not reported.
- Secondary findings on genes not included on the panel are not reported.
The service includes the detection of the following types of pathologies:
- The highly actionable ones of appearance during childhood.
- Those included in the neonatal biochemical test (heel prick test).
- Those that appear in adulthood but in which it is possible to be treated during childhood.
- The common ones, although they are not treatable, with a carrier frequency greater than 1/100.
Neonatal genetic analysis is an alternative that increases the range of heel prick test results.
The following comparative graph details the clinical application of the service in comparison to that test:
How does it work?
-
Select desired analysis and a specialist, then you have a video-consultation. -
Receive a sample collector kit at home that will be picked up by a courier. -
One of our partner labs makes the analysis. -
Your healthcare professional presents your results via videoconference.